Estrogen Decreases Osteoclast Formation by Down-regulating Receptor Activator of NF-κB Ligand (RANKL)-induced JNK Activation

Sunil Srivastava, Gianluca Toraldo, M. Neale Weitzmann, Simone Cenci, F. Patrick Ross, Roberto Pacifici

Research output: Contribution to journalArticle

Abstract

The differentiation of cells of the monocytic lineage into mature osteoclasts (OC) is specifically induced by the tumor necrosis factor-related factor, RANKL (receptor activator of NF-κB ligand; also known as OPGL, ODF, or TRANCE). Because inhibition of osteoclastogenesis is one of the main mechanisms by which estrogen (E2) prevents bone loss, it is likely that E2 may regulate either the production of, or the target cell responsiveness to RANKL. We found that E2 decreases the differentiation into OC of both murine bone marrow monocytes and RAW 264.7 cells, a monocytic line, by down-regulating the activation of Jun N-terminal kinase 1 (JNK1). Diminished JNK1 activity results in decreased nuclear levels of the key osteoclastogenic transcription factors, c-Fos and c-Jun, and lower binding of these transcriptional inducers to DNA. Thus, one novel mechanism by which E2 down-regulates osteoclastogenesis is by decreasing the responsiveness of OC precursors to RANKL.

Original languageEnglish
Pages (from-to)8836-8840
Number of pages5
JournalJournal of Biological Chemistry
Volume276
Issue number12
DOIs
Publication statusPublished - Mar 23 2001

Fingerprint

Osteoclasts
Estrogens
Chemical activation
Ligands
Osteogenesis
Bone
Phosphotransferases
Cell Lineage
Monocytes
Transcription Factors
Down-Regulation
Tumor Necrosis Factor-alpha
Bone Marrow
Cells
Bone and Bones
DNA

ASJC Scopus subject areas

  • Biochemistry

Cite this

Estrogen Decreases Osteoclast Formation by Down-regulating Receptor Activator of NF-κB Ligand (RANKL)-induced JNK Activation. / Srivastava, Sunil; Toraldo, Gianluca; Weitzmann, M. Neale; Cenci, Simone; Ross, F. Patrick; Pacifici, Roberto.

In: Journal of Biological Chemistry, Vol. 276, No. 12, 23.03.2001, p. 8836-8840.

Research output: Contribution to journalArticle

Srivastava, Sunil ; Toraldo, Gianluca ; Weitzmann, M. Neale ; Cenci, Simone ; Ross, F. Patrick ; Pacifici, Roberto. / Estrogen Decreases Osteoclast Formation by Down-regulating Receptor Activator of NF-κB Ligand (RANKL)-induced JNK Activation. In: Journal of Biological Chemistry. 2001 ; Vol. 276, No. 12. pp. 8836-8840.
@article{00d46b44209a4decaf6b6a135b6ee94e,
title = "Estrogen Decreases Osteoclast Formation by Down-regulating Receptor Activator of NF-κB Ligand (RANKL)-induced JNK Activation",
abstract = "The differentiation of cells of the monocytic lineage into mature osteoclasts (OC) is specifically induced by the tumor necrosis factor-related factor, RANKL (receptor activator of NF-κB ligand; also known as OPGL, ODF, or TRANCE). Because inhibition of osteoclastogenesis is one of the main mechanisms by which estrogen (E2) prevents bone loss, it is likely that E2 may regulate either the production of, or the target cell responsiveness to RANKL. We found that E2 decreases the differentiation into OC of both murine bone marrow monocytes and RAW 264.7 cells, a monocytic line, by down-regulating the activation of Jun N-terminal kinase 1 (JNK1). Diminished JNK1 activity results in decreased nuclear levels of the key osteoclastogenic transcription factors, c-Fos and c-Jun, and lower binding of these transcriptional inducers to DNA. Thus, one novel mechanism by which E2 down-regulates osteoclastogenesis is by decreasing the responsiveness of OC precursors to RANKL.",
author = "Sunil Srivastava and Gianluca Toraldo and Weitzmann, {M. Neale} and Simone Cenci and Ross, {F. Patrick} and Roberto Pacifici",
year = "2001",
month = "3",
day = "23",
doi = "10.1074/jbc.M010764200",
language = "English",
volume = "276",
pages = "8836--8840",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "12",

}

TY - JOUR

T1 - Estrogen Decreases Osteoclast Formation by Down-regulating Receptor Activator of NF-κB Ligand (RANKL)-induced JNK Activation

AU - Srivastava, Sunil

AU - Toraldo, Gianluca

AU - Weitzmann, M. Neale

AU - Cenci, Simone

AU - Ross, F. Patrick

AU - Pacifici, Roberto

PY - 2001/3/23

Y1 - 2001/3/23

N2 - The differentiation of cells of the monocytic lineage into mature osteoclasts (OC) is specifically induced by the tumor necrosis factor-related factor, RANKL (receptor activator of NF-κB ligand; also known as OPGL, ODF, or TRANCE). Because inhibition of osteoclastogenesis is one of the main mechanisms by which estrogen (E2) prevents bone loss, it is likely that E2 may regulate either the production of, or the target cell responsiveness to RANKL. We found that E2 decreases the differentiation into OC of both murine bone marrow monocytes and RAW 264.7 cells, a monocytic line, by down-regulating the activation of Jun N-terminal kinase 1 (JNK1). Diminished JNK1 activity results in decreased nuclear levels of the key osteoclastogenic transcription factors, c-Fos and c-Jun, and lower binding of these transcriptional inducers to DNA. Thus, one novel mechanism by which E2 down-regulates osteoclastogenesis is by decreasing the responsiveness of OC precursors to RANKL.

AB - The differentiation of cells of the monocytic lineage into mature osteoclasts (OC) is specifically induced by the tumor necrosis factor-related factor, RANKL (receptor activator of NF-κB ligand; also known as OPGL, ODF, or TRANCE). Because inhibition of osteoclastogenesis is one of the main mechanisms by which estrogen (E2) prevents bone loss, it is likely that E2 may regulate either the production of, or the target cell responsiveness to RANKL. We found that E2 decreases the differentiation into OC of both murine bone marrow monocytes and RAW 264.7 cells, a monocytic line, by down-regulating the activation of Jun N-terminal kinase 1 (JNK1). Diminished JNK1 activity results in decreased nuclear levels of the key osteoclastogenic transcription factors, c-Fos and c-Jun, and lower binding of these transcriptional inducers to DNA. Thus, one novel mechanism by which E2 down-regulates osteoclastogenesis is by decreasing the responsiveness of OC precursors to RANKL.

UR - http://www.scopus.com/inward/record.url?scp=0035937747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035937747&partnerID=8YFLogxK

U2 - 10.1074/jbc.M010764200

DO - 10.1074/jbc.M010764200

M3 - Article

C2 - 11121427

AN - SCOPUS:0035937747

VL - 276

SP - 8836

EP - 8840

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 12

ER -